Posted on February 7, 2019 by Sitemaster
It has long been appreciated that African-American males have higher risk for diagnosis with prostate cancer, and higher risk for prostate cancer-specific mortality, than those of other ethnic origins living in the US. … READ MORE …
Filed under: Uncategorized | Tagged: African American, aggressiveness, decision-making, disparity, race, Treatment, white | 7 Comments »
Posted on April 20, 2016 by Sitemaster
Data from the North Carolina-Louisiana Prostate Cancer Project, a projected funded by the Department of Defense’s Prostate Cancer Research Program, have again shown that diets high in saturated fats seem to increase risk for aggressive forms of prostate cancer. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: aggressiveness, diet, fat, risk, saturated, statin, unsaturated | Leave a comment »
Posted on April 7, 2016 by Sitemaster
A news story on the web site of St. George’s University in London, England, offers some interesting information about research into the very early stages of the development of prostate cancer — a problem about which we still know very little. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: acini, aggressiveness, Diagnosis, risk | Leave a comment »
Posted on October 3, 2014 by Sitemaster
An article just published on line in Clinical Cancer Research supposedly reports the discovery of a single nucleotide polymorphism or SNP that may be useful in predicting which patients with Gleason 7 disease are most likely to have a more aggressive form of cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: aggressiveness, biomarker, Gleason, grade, KLK3, nucleotide, polymorphism, single, SNP | 1 Comment »
Posted on January 4, 2013 by Sitemaster
According to an article published on line in Cancer Research, a research team at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia is claiming that they have identified an “oncogene signature” that is highly predictive for aggressive forms of prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: aggressiveness, oncogene, risk, signature | Leave a comment »
Posted on May 14, 2012 by Sitemaster
According to a media release from the Mayo Clinic earlier today, “Alterations to the ‘on-off’ switches of genes occur early in the development of prostate cancer and could be used as biomarkers to detect the disease months or even years earlier than current approaches.” … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: aggressiveness, DNA, expression, gene, methylation, test | 2 Comments »
Posted on July 7, 2010 by Sitemaster
Beta-2 -microglobulin (also known as β2-microglobulin or B2M) is a well-characterized protein that has been investigated for years because of its importance in the diagnosis and staging of patients with some types of blood cancer (lymphomas and multiple myeloma). … READ MORE …
Filed under: Diagnosis, Drugs in development, Risk | Tagged: aggressiveness, B2M, beta-2-microglobulin, prognosis, risk | Leave a comment »
Posted on May 20, 2010 by Sitemaster
We are starting to see a increase in the publication of data about [-2]proPSA — a specific type or isoform of free PSA — and its potential relevance in the detection and diagnosis of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk, Uncategorized | Tagged: aggressiveness, biopsy, detection, [-2]proPSA | Leave a comment »
Posted on July 2, 2009 by Sitemaster
Today’s news reports discuss such issues as:
- Sextant biopsy in diagnosis of unilateral prostate cancer
- Aggressiveness of prostate cancer in man diagnosed with PSA < 4 ng/ml
- The potential of 3T MRI in prostate cancer prognosis pre-surgery
- Surgical margins and risk for biochemical recurrence post-surgery … READ MORE …
Filed under: Uncategorized | Tagged: 3T MRI, aggressiveness, biopsy, low PSA levels, prognosis, risk, sextant, surgical margins | Leave a comment »
Posted on March 9, 2009 by Sitemaster
A recently published study has suggested the possibility of an association between the aggressiveness of prostate cancer and degree of glycemic control in some patients with an existing diagnosis of diabetes. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: aggressiveness, diabetes, glycemic control, HbA1c | Leave a comment »
Posted on February 13, 2009 by Sitemaster
After a relatively quiet news period, the flood gates have opened again, so we shall divide today’s news reports into two postings for easier reading. We have also published a separate report on the possibility of an association between alcohol use and prostate cancer diagnosis. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: active surveillance, aggressiveness, androgen resistance, avanafil, ED, erectile dysfunction, p63, prognosis, survival, vitamin D | Leave a comment »